Brain angiogenesis in developmental and pathological processes: Therapeutic aspects of vascular endothelial growth factor

FEBS Journal

Volumn 276, Issue 17, 2009, Pages 4636-4643

  Shibuya, Masabumi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JOBU UNIVERSITY   (Japan)

Author keywords

Macrophage; Malignant glioma; Motor neuron; Tumor angiogenesis; Vascular hyperpermeability; VEGF A; VEGF B; VEGF E; VEGFR 1; VEGFR 2

Indexed keywords

ANGIOPOIETIN RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN FUNCTION; BRAIN TUMOR; CANCER SURVIVAL; CELL COMMUNICATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; HUMAN; MOTONEURON; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR GROWTH; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL COMMUNICATION; GLIOMA; HUMANS; MOTOR NEURONS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE DEGENERATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68849084613     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07175.x     Document Type: Short Survey

References (36)

1. Ferrara N, Gerber HP LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9, 669 679.
2. Shibuya M (2008) Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep 41, 278 286.
3. de Almodovar CR, Zacchigna S Carmeliet P (2008) Angiogenesis in the central nervous system. In Angiogenesis: An Integrative Approach from Science to Medicine (Figg W Folkmann J, eds) pp. 489 504. Springer, New York, NY.
4. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ Kim KW (2003) SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9, 900 906.
5. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N Shibuya M (2005) Essential role of Flk-1 (vascular endothelial growth factor receptor-2) tyrosine residue-1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 102, 1076 1081.
6. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T Shibuya M (2001) Vascular endothelial growth factor receptor-1 (Flt-1) is a novel cell surface marker for the lineage of monocytes-macrophages in humans. Blood 97, 785 791.
7. Kiba A, Sagara H, Hara T Shibuya M (2003) VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem Biophys Res Commun 301, 371 377.
8. NZ7/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Arterioscler Thromb Vasc Biol 26, 2019 2026.
9. Takahashi H, Hattori S, Iwamatsu A, Takizawa H Shibuya M (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J Biol Chem 279, 46304 46314.
10. Plate KH, Breier G, Weich HA, Mennel HD Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59, 520 529.
11. Kargiotis O, Rao JS Kyritsis AP (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol 78, 281 293.
12. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP Iruela-Arispe ML (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691 703.
13. Alitalo K Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219 227.
14. Heiss WD, Sobesky J Hesselmann V (2004) Identifying thresholds for penumbra and irreversible tissue damage. Stroke 35 (11 Suppl 1 2671 2674.
15. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N Chopp M (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106, 829 838.
16. Inoue N, Kondo T, Kobayashi K, Aoki M, Numaguchi Y, Shibuya M Murohara T (2007) Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler Thromb Vasc Biol 27, 99 105.
17. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM et al. (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451, 1008 1012.
18. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S et al. (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28, 131 138.
19. Sun Y, Jin K, Childs JT, Xie L, Mao XO Greenberg DA (2006) Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 289, 329 335.
20. Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A et al. (2008) Novel role for VEGF-receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 28, 10451 10459.
21. Hiratsuka S, Minowa O, Kuno J, Noda T Shibuya M (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95, 9349 9354.
22. Fueyo J, Gomez-Manzano C, Yung WKA Kyritsis AP (1998) The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies. Neurology 51, 1250 1255.
23. Prigent SA, Nagane M, Lin H, Huvar I, Boss GR, Feramisco JR, Cavenee WK Huang HS (1996) Enhanced tumorigenic behaviour of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem 271, 25639 25645.
24. Saleh M, Stacker SA Wilks AF (1996) Inhibition of growth of C6glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 5, 393 401.
25. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K Huang S (2008) FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 68, 8733 8742.
26. Ido K, Nakagawa T, Sakuma T, Takeuchi H, Sato K Kubota T (2008) Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors. Neuropathology 28, 604 611.
27. Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate KH et al. (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res 68, 7342 7351.
28. Lin EY Pollard JW (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67, 5064 5066.
29. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350, 2335.
30. Jain RK, Tong RT Munn LL (2007) Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 67, 2729.
31. Vredenburgh JJ, Desjardins A, Herndon JE 2nd., Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M et al. (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13, 1253.
32. Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, Ciampa AS, Ebbeling LG, Levy B, Drappatz J et al. (2008) Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology 70, 779 787.
33. Zuniga RM, Torcuator R, Jain R, Anderson J, Doyle T, Ellika S, Schultz L Mikkelsen T (2009) Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. J Neurooncol 91, 329 336.
34. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF Shuman MA (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2, 306 314.
35. Aiello LP, George DJ, Cahill MT, Wong JS, Cavallerano J, Hannah AL Kaelin WG Jr. (2002) Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. Ophthalmology 109, 1745 1751.
36. Osawa T, Muramatsu M, Watanabe M Shibuya M (2009) Hypoxia and low nutrition double stress induces aggressiveness in a murine model of melanoma. Cancer Sci 100, 844 851.